---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-059673"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T13:34:12.969409+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InMed Pharma raises $5M in private placement of pre-funded warrants and options

## Summary
- Gross proceeds ~$5M from 1,952,363 pre-funded warrants ($0.0001 exercise) and 1,952,363 preferred investment options at $2.436/share.
- Amended 199,115 existing options (Oct 2023) from $16.60 to $2.436 per share for $0.125 each.
- Proceeds to fund pipeline development, BayMedica commercial sales, and working capital.
- H.C. Wainwright acted as placement agent; received 126,904 agent options at $3.2013/share.

## SEC filing metadata
- accession: 0001213900-25-059673
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/0001213900-25-059673-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/ea0247476-8k_inmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-059673
- JSON: https://secwatch.observer/filing/0001213900-25-059673.json
- Plain text: https://secwatch.observer/filing/0001213900-25-059673.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.